Format

Send to

Choose Destination
Acta Pharmacol Sin. 2019 May;40(5):689-698. doi: 10.1038/s41401-018-0157-9. Epub 2018 Aug 31.

Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties.

Author information

1
Department of Pharmacy, The Second Hospital of Shandong University, Jinan, 250033, China.
2
Department of Natural Product Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, 250012, China.
3
Emergency Center, Shandong Provincial Hospital affiliated to Shandong University, Jinan, 250021, China.
4
Department of Dermato-venereology, The Second Hospital of Shandong University, Jinan, 250033, China.
5
Central Research Laboratory, The Second Hospital of Shandong University, Jinan, 250033, China.
6
Department of Biochemistry and Molecular Biology, School of Medicine, Shandong University, Jinan, 250012, China.
7
Department of Pharmacy, The Second Hospital of Shandong University, Jinan, 250033, China. rongmeiwang@hotmail.com.
8
Department of Natural Product Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, 250012, China. louhongxiang@sdu.edu.cn.

Abstract

Acquired docetaxel-resistance of prostate cancer (PCa) remains a clinical obstacle due to the lack of effective therapies. Acetyl-11-keto-β-boswellic acid (AKBA) is a pentacyclic triterpenic acid isolated from the fragrant gum resin of the Boswellia serrata tree, which has shown intriguing antitumor activity against human cell lines established from PCa, colon cancer, malignant glioma, and leukemia. In this study, we examined the effects of AKBA against docetaxel-resistant PCa in vitro and in vivo as well as its anticancer mechanisms. We showed that AKBA dose-dependently inhibited cell proliferation and induced cell apoptosis in docetaxel-resistant PC3/Doc cells; its IC50 value in anti-proliferation was ∼17 μM. Furthermore, AKBA dose-dependently suppressed the chemoresistant stem cell-like properties of PC3/Doc cells, evidenced by significant decrease in the ability of mammosphere formation and down-regulated expression of a number of stemness-associated genes. The activation of Akt and Stat3 signaling pathways was remarkably enhanced in PC3/Doc cells, which contributed to their chemoresistant stem-like phenotype. AKBA (10-30 μM) dose-dependently suppressed the activation of Akt and Stat3 signaling pathways in PC3/Doc cells. In contrast, overexpression of Akt and Stat3 significantly attenuated the inhibition of AKBA on PC3/Doc cell proliferation. In docetaxel-resistant PCa homograft mice, treatment with AKBA significantly suppresses the growth of homograft RM-1/Doc, equivalent to its human PC3/Doc, but did not decrease their body weight. In summary, we demonstrate that AKBA inhibits the growth inhibition of docetaxel-resistant PCa cells in vitro and in vivo via blocking Akt and Stat3 signaling, thus suppressing their cancer stem cell-like properties.

KEYWORDS:

Akt; Stat3; acetyl-11-keto-β-boswellic acid; chemoresistant stem cell-like properties; docetaxel-resistance; prostate cancer

PMID:
30171201
DOI:
10.1038/s41401-018-0157-9

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center